PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15825631

Drug utilization: using objective data to achieve cost-efficiency.

Bridget L Eber
View original source ↗Export metadata ↓

Abstract

By grading pharmacy benefit managers' (PBMs') performance using an objective evaluation process, employers can identify specific opportunities and establish measurable goals to define efficient drug utilization. Many employers come away from the grading process with a similar conclusion--Increased generic dispensing is a must for achieving delivery of an affordable prescription drug benefit. By focusing on the conditions that affect their population, employers are ensuring that PBMs implement practical programs that make it easy for physicians to prescribe affordable high-value drugs.

Explore related subjects

Cost SavingsCost-Benefit AnalysisDrug CostsDrug Utilization ReviewInsurance, Pharmaceutical ServicesUnited StatesEvaluation StudyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bridget L Eber. 2005. Drug utilization: using objective data to achieve cost-efficiency.. https://pubmed.ncbi.nlm.nih.gov/15825631/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Economic impact of shifting the locus of care for neuropathic pain from specialists to general practitioners.

We developed a decision-analytic model to examine the economic impact of shifting the locus of care for patients with painful neuropathies from specialists to GPs. The impetus for such a shift was assumed to be a formal education program, focusing on the recognition and treatment of neuropathic pain, conducted for GPs. In the model, all patients with neuropathic pain were assumed to initiate care with their GPs and then be referred to specialists and, ultimately, pain clinics as required for adequate pain control. Two alternative scenarios were examined--the "current" arrangement in which most patients were assumed to be referred for treatment by specialists and pain clinics and a "hypothetical" arrangement in which GPs were assumed to play an expanded role in the treatment of neuropathic pain and which, therefore, often precluded the need for referral. The model was populated with clinical, epidemiologic, and economic data from Norway. A total of 34,951 persons in Norway were estimated to seek care for painful neuropathies each year. The formal education program was assumed to cost 1.5 million Kroner (NOK). Shifting the locus of care from specialists to GPs would result in 4,715 additional GP visits, but 12,123 fewer specialist visits and 7,967 fewer visits to pain clinics. This change would result in estimated savings to the Norwegian health-care system in 2004 of 74.1 million NOK (approx. US $11.9 million). A partial shift in the locus of care of painful neuropathies from specialists to GPs may result in substantial cost savings to the Norwegian health-care system.

Cost Savings↗
PubMed2007

Decision analysis model of incisional hernia after open abdominal surgery.

BACKGROUND: The incidence rate of incisional hernias after open surgery has been reported to be higher than that of port site hernias after laparoscopic surgery. No studies have compared the costs for the health care system in treating those two types of hernia. METHODS: A systematic review was conducted to obtain the baseline data, and a decision analysis model was created to simulate the occurrence and recurrence of incisional and port site hernias. RESULTS: The overall risk of having incisional hernias was eight-times higher than that of having port site hernias (7.4% vs 0.9%). A cost savings of 93 British Pound per patient can be generated for the health care system in the UK. Similar results were obtained for Germany, Italy and France. CONCLUSIONS: The additional treatment costs for incisional hernia should be taken into account when the costs of a surgery performed by open approach are compared with by laparoscopy.

Cost Savings↗